Showing results (241-250 of 250) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 250 results.
The Journal of Clinical Investigation|January 17, 2018
OATP1B2 deficiency protects against paclitaxel-induced neurotoxicityAlix F Leblanc, Jason A Sprowl, Paola Alberti, et al.
American Journal of Physical Medicine & Rehabilitation|April 14, 2021
Evidence-Based Medicine Training in United States-Based Physiatry Residency ProgramsThiru M Annaswamy, John-Ross Rizzo, Amy Schnappinger, et al.
Science Advances|April 8, 2026
Vasculogenic tissue nanotransfection accelerates functional recovery after peripheral nerve injuryAna I Salazar-Puerta, Sara Kheirkhah, Jonathan P Stranan, et al.
Contemporary Clinical Trials Communications|August 11, 2018
Recruitment & retention program for the NeuroNEXT SMA Biomarker Study: Super Babies for SMA!Amy Bartlett, Stephen J Kolb, Allison Kingsley, et al.
Science Advances|March 20, 2021
Nanotransfection-based vasculogenic cell reprogramming drives functional recovery in a mouse model of ischemic strokeLuke R Lemmerman, Maria H H Balch, Jordan T Moore, et al.
Journal of the American Geriatrics Society|March 10, 2020
Sarcopenia Definition: The Position Statements of the Sarcopenia Definition and Outcomes ConsortiumShalender Bhasin, Thomas G Travison, Todd M Manini, et al.
Molecular Therapy. Advances|May 15, 2026
Preclinical evaluation of INS1201 AAV9-micro-dystrophin via CSF administration as a potential therapy for Duchenne muscular dystrophyGretchen Thomsen, Allan Kaspar, Laura Ferraiuolo, et al.
Annals of Neurology|November 18, 2017
Natural history of infantile-onset spinal muscular atrophyStephen J Kolb, Christopher S Coffey, Jon W Yankey, et al.
Annals of Clinical and Translational Neurology|February 23, 2016
Baseline results of the NeuroNEXT spinal muscular atrophy infant biomarker studyStephen J Kolb, Christopher S Coffey, Jon W Yankey, et al.
Pageof 25